Andrew Faller
8Patents
4h-index
16Co-inventors
54Inventor score
Filing activity: Jan 21, 1999 → Jun 14, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7253198B2 | Hydroxyethylamine derivatives for the treatment of Alzheimer's disease | Chemistry; Metallurgy | 52 | Expired |
| US6992103B2 | Benzamide derivatives, processes for their preparation, and their pharmaceutical use | Chemistry; Metallurgy | 22 | Expired |
| US6673965B1 | Hydroxamic acid derivative as inhibitor of the formation of soluble human CD23 | Chemistry; Metallurgy | 10 | Expired |
| US6235753A | Inhibitors of the production of S-CD23 and the secretion of TNF | Chemistry; Metallurgy | 4 | Expired |
| US6242467A | Compounds | Chemistry; Metallurgy | 2 | Expired |
| US6458779B1 | Hydroxamic acid derivatives as inhibitors of the production of human CD23 and of the TNF release | Chemistry; Metallurgy | 1 | Expired |
| US11214576B2 | 2,3-dihydrofuro[2,3-b]pyridine compounds | Performing Operations; Transporting | 0 | Active |
| US7160905B2 | Hydroxyethylene compounds with Asp2 inhibitory activity | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.